Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty

Inclusion Criteria: * At least 18 years of age * Male or female patient who had endothelial keratoplasty procedure within the past 1 to 7 weeks * Patient is able and willing to administer eye drops * Patient is able to comprehend and has signed the Informed Consent form. * Patient is likely to complete the one-year course of the study Exclusion Criteria: * A history of a previous rejection episode in the study eye * A patient exhibiting intraocular inflammation * A patient with a known sensitivity to any of the ingredients in the study medications * A patient who has a condition (i.e., UNCONTROLLED systemic disease) or is in a situation which in the investigator's opinion may put the patient at significant risk, may confound the study results, or may interfere significantly with the patient's participation in the study * A patient with abnormal eyelid function. * A patient that is exhibiting active corneal ulceration, keratitis, or conjunctivitis, or who has a history of herpetic keratitis. * Presence of any ocular disease that would interfere with the evaluation of the study treatment. However, patients with a history of cystoid macular edema, age-related macular degeneration, controlled glaucoma, corneal neovascularization, and other non-interfering comorbidities may be enrolled. * A patient with a history of non-compliance with using prescribed medication. * A patient who is concurrently involved in or participated in another randomized clinical trial within 30 days prior to enrollment in this study. * Patients who are pregnant or planning to become pregnant within the duration of the study